Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

The Dana-Farber Cancer Institute (DFCI) ALL Consortium has been conducting multi-institutional clinical trials in childhood ALL since 1981. The treatment backbone has included 20–30 consecutive weeks of asparaginase during intensification and frequent vincristine/corticosteroid pulses during the con...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Silverman, Lewis B., Stevenson, Kristen E., O’Brien, Jane E., Asselin, Barbara L., Barr, Ronald D., Clavell, Luis, Cole, Peter D., Kelly, Kara, Laverdiere, Caroline, Michon, Bruno, Schorin, Marshall A., Schwartz, Cindy L., O’Holleran, Eileen Whyte, Neuberg, Donna S., Cohen, Harvey J., Sallan, Stephen E.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2820141/
https://ncbi.nlm.nih.gov/pubmed/20016537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2009.253
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires